Health Care: Drugs

Novogen Ltd (NVGN: NASDAQ)

$2.97 0.03 | 1.02%
09/19/14 - 03:34 PM ET
Company Income Statement
Jun 2013 Jun 2012 Jun 2011 Jun 2010
Sales 1.56M 2.51M 2.16M 8.42M
Cost of Sales 0.00 0.00 0.00 1.72M
Gross Operating Profit 1.56M 2.51M 2.16M 6.71M
Selling, General, and Administrative Expenses 2.64M 5.93M 10.22M 12.60M
Research & Development 237.54K 5.53M 4.17M 6.88M
Operating Income before D & A (EBITDA) -1.32M -8.95M -12.23M -12.77M
Depreciation & Amortization 311.78K 25.60K 88.71K 168.27K
Interest Income 41.76K 0.00 0.00 0.00
Other Income - Net 0.00 0.00 547.21K 5.95K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -1.59M -8.98M -11.77M -12.94M
Interest Expense 122.48K 0.00 19.24K 12.75K
Pre-Tax Income -1.71M -8.98M -11.79M -12.95M
Income Taxes 0.00 0.00 1.07K 8.50K
Minority Interest 228.26K -2.72M -3.19M -2.47M
Net Income From Continuing Operations -1.40M -8.95M -11.70M -12.96M
Net Income From Discontinued Operations 670.87K 7.57M 1.57M 0.00
Net Income From Total Operations -728.40K -1.38M -10.13M -12.96M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -956.67K 1.34M -6.94M -10.49M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-1.40M -8.95M -11.70M -12.96M
Preferred Dividends
Net Income Available To Common -1.40M -8.95M -11.70M -12.96M
Basic EPS from Continuing Ops. -30.50 -1.51 -2.08 -2.70
Basic EPS from Discontinued Ops. 9.65 1.84 0.37 0.00
Basic EPS from Total Operations -20.85 0.33 -1.71 -2.70
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.13
Basic EPS, Total -20.85 0.33 -1.71 -2.57
Basic Normalized Net Income/Share -30.50 -1.51 -2.08 -2.70
EPS fr Continuing Ops. -30.50 -1.51 -2.08 -2.70
EPS fr Discontinued Ops 9.65 1.84 0.37 0.00
EPS fr Total Ops. -20.85 0.33 -1.71 -2.70
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.13
EPS, Total -20.85 0.33 -1.71 -2.57
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-30.50 -1.51 -2.08 -2.70
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with NVGN

Latest NVGN Headlines from TheStreet

More Financial News for NVGN

Press Releases for NVGN

See All Press Releases

Partner Headlines for NVGN

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter